Microbiology sectional 2

Quiz

Explain the fundamental principle behind recombinant DNA technology and provide one example of its application in biotechnology.
Describe the basic structure of a virus and differentiate it from a bacterium in terms of reproduction.
What is the significance of normal microbiota in the human body? Give one example of a beneficial function they perform.
Distinguish between microbial pathogenicity and virulence. How might a microorganism with low pathogenicity still cause disease?
Define innate immunity and provide two examples of physical or chemical barriers that contribute to it.
Explain the concept of selective toxicity as it relates to antimicrobial drugs. Why is this concept crucial for effective treatment?
Outline the main steps involved in the lytic cycle of viral multiplication.
Describe the difference between a pandemic and an epidemic in the context of disease occurrence.
What are plasmids, and how can they contribute to bacterial pathogenicity?
Describe the process of phagocytosis. What are the primary types of cells involved in this process?

Quiz Answer Key

Recombinant DNA technology involves combining genetic material from different sources to create new DNA molecules. This allows for the manipulation of genes for various purposes, such as producing therapeutic proteins like insulin in bacteria.
A virus consists of genetic material (DNA or RNA) enclosed in a protein coat called a capsid, and sometimes an outer envelope. Unlike bacteria, viruses are obligate intracellular parasites and require a host cell to replicate.
Normal microbiota are the microorganisms that reside on or within the human body without causing disease under normal circumstances. They perform vital functions such as aiding in digestion and competing with potential pathogens for resources and space.
Pathogenicity is the ability of a microorganism to cause disease, while virulence is the degree or extent of pathogenicity. A microorganism with low pathogenicity might still cause disease in immunocompromised individuals or if present in very high numbers.
Innate immunity is the body's non-specific, first-line defense against pathogens, present from birth. Examples of physical barriers include the skin and mucous membranes, while chemical barriers include stomach acid and lysozyme in tears.
Selective toxicity refers to the ability of an antimicrobial drug to kill or inhibit the growth of a target microorganism without significantly harming the host's cells. This is crucial because it allows for the treatment of infections with minimal side effects on the patient.
The lytic cycle involves the virus attaching to a host cell, penetrating it, replicating its genetic material and proteins, assembling new viral particles (virions), and finally lysing (rupturing) the host cell to release the newly formed virions.
An epidemic is a sudden increase in the number of cases of a disease above what is normally expected in a particular population and area. A pandemic is an epidemic that has spread over several countries or continents, usually affecting a large number of people.
Plasmids are small, circular DNA molecules that are separate from a bacterium's main chromosome. They can carry genes that contribute to pathogenicity, such as those encoding for toxins or antibiotic resistance, which can then be transferred between bacteria.
Phagocytosis is the process by which certain cells engulf and digest foreign particles, such as bacteria and cellular debris. The primary cells involved include neutrophils and macrophages, which extend pseudopods to surround the particle and internalize it into a phagosome where it is broken down by enzymes.

Essay Format Questions

Discuss the diverse applications of genetic engineering in fields such as medicine, agriculture, and industry. Analyze the potential benefits and risks associated with these applications, considering ethical implications.
Compare and contrast the mechanisms of action of different types of antimicrobial drugs, providing specific examples. Evaluate the growing challenge of antimicrobial resistance and propose strategies to mitigate its spread.
Describe the key stages of a viral infection, from attachment to release. Explain how the lytic and lysogenic cycles differ, and discuss the implications of these different life cycles for viral pathogenesis and latency.
Explain the interconnectedness of the concepts of normal microbiota, pathogenicity, and the spread of infectious diseases. Discuss how disruptions in the normal microbiota can increase susceptibility to infection and how various factors contribute to the transmission of pathogens.
Outline the major components and mechanisms of the innate and adaptive immune systems. Discuss how these two branches of the immune system work together to protect the body against infection, and provide examples of how pathogens can evade immune responses.

Glossary of Key Terms

Biotechnology: The application of biological knowledge to create products and processes for various purposes, including medicine, agriculture, and industry.
Recombinant DNA: DNA molecules formed by laboratory methods that combine genetic material from multiple sources, creating sequences not found in nature.
Gene Therapy: The introduction of genetic material into cells to treat or prevent disease.
Genetic Engineering: The modification of an organism's genetic material using biotechnology.
Virus: An infectious agent that is acellular, possessing genetic material (DNA or RNA) enclosed in a protein coat, and capable of replicating only within a living host cell.
Viroid: An infectious entity composed only of a small, circular single-stranded RNA molecule that does not encode proteins.
Prion: An infectious agent composed of misfolded protein that can transmit its abnormal folded state to normal variants of the same protein.
Lytic Cycle: A viral reproductive cycle that culminates in the lysis (destruction) of the host cell and the release of newly produced virions.
Lysogenic Cycle: A viral reproductive cycle in which the viral DNA integrates into the host cell's chromosome and remains dormant for an extended period, being replicated along with the host DNA.
Normal Microbiota: The community of microorganisms (bacteria, fungi, protozoa, and viruses) that live in and on the human body without causing disease under normal circumstances.
Pathogenicity: The ability of a microorganism to cause disease.
Virulence: The degree or extent of pathogenicity of a microorganism.
Epidemiology: The study of the distribution and determinants of health-related states or events (including disease), and the application of this study to the control of diseases and other health problems.
Plasmid: A small, circular DNA molecule that is separate from a bacterium's chromosomal DNA and can replicate independently.
Lysogeny: The state in which a phage genome is integrated into the host bacterial chromosome.
Innate Immunity: The body's non-specific defense mechanisms that are present from birth and provide immediate protection against a wide range of pathogens.
Adaptive Immunity: The body's specific defense mechanisms that develop over time in response to exposure to specific antigens and provide long-lasting immunity.
Phagocytosis: The process by which certain cells (e.g., macrophages, neutrophils) engulf and digest foreign particles, including microorganisms.
Inflammation: A localized physical condition in which part of the body becomes reddened, swollen, hot, and often painful, especially as a reaction to injury or infection.
Antimicrobial Drug: A chemical substance that kills or inhibits the growth of microorganisms.
Chemotherapy: The use of chemical substances to treat diseases, particularly infections and cancer.
Selective Toxicity: The ability of an antimicrobial drug to kill or inhibit the growth of a target microorganism without significantly harming the host's cells.
Antimicrobial Resistance: The ability of microorganisms to withstand the effects of antimicrobial drugs to which they were once susceptible.
Spectrum of Antimicrobial Activity: The range of different microorganisms that an antimicrobial drug is effective against.

convert_to_textConvert to source

NotebookLM can be inaccurate; please double check its responses.